Genetic overlap between holoprosencephaly and Kallmann syndrome

Molecular Syndromology

Volumn 3, Issue 1, 2012, Pages 1-5

  Vaaralahti, K ^a,b   Raivio, T ^a,b   Koivu, R ^a,b   Valanne, L ^c   Laitinen, E M ^a,b   Tommiska, J ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Holoprosencephaly; Kallmann syndrome; Septo optic dysplasia

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; BRAIN MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HOLOPROSENCEPHALY; HUMAN; KALLMANN SYNDROME; MALE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPTOOPTIC DYSPLASIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862490762     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000338706     Document Type: Article

References (46)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al: A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249 (2010).
2. Arauz RF, Solomon BD, Pineda-Alvarez DE, Gropman AL, Parsons JA, et al: A hypomorphic allele in the FGF8 gene contributes to holoprosencephaly and is allelic to gonadotropin- releasing hormone deficiency in humans. Mol Syndromol 1: 59-66 (2010).
3. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, et al: Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 14: 353-356 (1996).
4. Bianco SD, Kaiser UB: The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol 5: 569-576 (2009).
5. Cariboni A, Maggi R: Kallmann's syndrome, a neuronal migration defect. Cell Mol Life Sci 63: 2512-2526 (2006).
6. Cohen MM Jr: Holoprosencephaly: clinical, anatomic, and molecular dimensions. Birth Defects Res A Clin Mol Teratol 76: 658-673 (2006).
7. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, et al: Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genet 19: 125-133 (1998).
8. de la Cruz JM, Bamford RN, Burdine RD, Roessler E, Barkovich AJ, et al: A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum Genet 110: 422-428 (2002).
9. Demyer W, Zeman W: Alobar holoprosencephaly (arhinencephaly) with median cleft lip and palate: clinical, electroencephalographic and nosologic considerations. Confin Neurol 23: 1-36 (1963).
10. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le DÛ N, et al: Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33: 463-465 (2003).
11. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, et al: Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2:e175 (2006).
12. Dubourg C, Bendavid C, Pasquier L, Henry C, Odent S, David V: Holoprosencephaly. Orphanet J Rare Dis 2: 8 (2007).
13. Engelen E, Akinci U, Bryne JC, Hou J, Gontan C, et al: Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet 43: 607-611 (2011).
14. Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, et al: Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 118: 2822-2831 (2008).
15. França MM, Jorge AA, Carvalho LR, Costalonga EF, Vasques GA, et al: Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. J Clin Endocrinol Metab 95:E384-E391 (2010).
16. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, et al: A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353: 529-536 (1991).
17. Gripp KW, Wotton D, Edwards MC, Roessler E, Ades L, et al: Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat Genet 25: 205-208 (2000).
18. Kang S, Graham JM Jr, Olney AH, Biesecker LG: GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 15: 266-268 (1997).
19. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, et al: Mutations in CHD7, encoding a chromatin- remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 83: 511-519 (2008).
20. Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, et al: WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 87: 465-479 (2010).
21. Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, et al: Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis 6: 41 (2011).
22. Lazaro L, Dubourg C, Pasquier L, Le Duff F, Blayau M, et al: Phenotypic and molecular variability of the holoprosencephalic spectrum. Am J Med Genet A 129A:21-24 (2004).
23. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, et al: The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67: 423-435 (1991).
24. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, et al: Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25: 2744-2750 (2009).
25. McCabe MJ, Alatzoglou KS, Dattani MT: Septooptic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab 25: 115-124 (2011a).
26. McCabe MJ, Gaston-Massuet C, Tziaferi V, Gregory LC, Alatzoglou KS, et al: Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. J Clin Endocrinol Metab 96:E1709-E1718 (2011b).
27. Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, et al: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 104: 17447-17452 (2007a).
28. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, at al: Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117: 457-463 (2007b).
29. Raivio T, Sidis Y, Plummer L, Chen H, Ma J, et al: Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 94: 4380-4390 (2009).
30. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, et al: Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab (2012), E-pub ahead of print.
31. Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, et al: Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA 100: 13424-13429 (2003).
32. Roessler E, Ouspenskaia MV, Karkera JD, Vélez JI, Kantipong A, et al: Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet 83: 18-29 (2008).
33. Roessler E, Vélez JI, Zhou N, Muenke M: Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene ! gene interactions. Mol Genet Metab 105: 658-664 (2012).
34. Sato N, Kamachi Y, Kondoh H, Shima Y, Morohashi K, et al: Hypogonadotropic hypogonadism in an adult female with a heterozygous hypomorphic mutation of SOX2 . Eur J Endocrinol 156: 167-171 (2007).
35. Schwanzel-Fukuda M, Bick D, Pfaff DW: Luteinizing hormone-releasing hormone (LHRH)- expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 6: 311-326 (1989).
36. Seminara SB, Hayes FJ, Crowley WF Jr: Gonadotropin- releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 19: 521-539 (1998).
37. Semple RK, Topaloglu AK: The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions. Clin Endocrinol (Oxf) 72: 427-435 (2010).
38. Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, et al: Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab 96: 566-576 (2011).
39. Solomon BD, Mercier S, Vélez JI, Pineda-Alvarez DE, Wyllie A, et al: Analysis of genotypephenotype correlations in human holoprosencephaly. Am J Med Genet C Semin Med Genet 154C:133-141 (2010).
40. Stark Z, Storen R, Bennetts B, Savarirayan R, Jamieson RV: Isolated hypogonadotropic hypogonadism with SOX2 mutation and anophthalmia/ microphthalmia in offspring. Eur J Hum Genet 19: 753-756 (2011).
41. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, et al: Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 107: 15140-15144 (2010).
42. Teixeira L, Guimiot F, Dodé C, Fallet-Bianco C, Millar RP, et al: Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. J Clin Invest 120: 3668-3672 (2010).
43. Wallis DE, Muenke M: Molecular mechanisms of holoprosencephaly. Mol Genet Metab 68: 126-138 (1999).
44. Webb EA, Dattani MT: Septo-optic dysplasia. Eur J Hum Genet 18: 393-397 (2010).
45. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE: Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 29: 6-13 (2008).
46. Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, et al: Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 15: 1413-1422 (2006).